Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma

Citation
B. Meister et al., Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma, EUR J CANC, 35(3), 1999, pp. 445-449
Citations number
28
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
EUROPEAN JOURNAL OF CANCER
ISSN journal
09598049 → ACNP
Volume
35
Issue
3
Year of publication
1999
Pages
445 - 449
Database
ISI
SICI code
0959-8049(199903)35:3<445:EOVEGF>2.0.ZU;2-0
Abstract
Angiogenic factors may play a role in the biology of neuroblastoma, a well vascularised tumour, which frequently spreads haematogenously. Therefore, w e analysed expression of vascular endothelial growth factor (VEGF) in six h uman neuroblastoma cell lines and five primary neuroblastomas. High VEGF le vels (1-3 ng/10(6) cells/day) were found in the supernatant of all cell lin es examined (SK-N-LO, SK-N-SH, LS, SH-SY5Y, IMR-32, Kelly). VEGF peptide wa s also detected in tissue homogenates from four of five primary tumours. Re verse transcript ion-polymerase chain reaction (RT-PCR) revealed that VEGF( 165) is the major isoform produced by neuroblastomas. In addition, all cell lines and primary tumours expressed the mitogenic VEGF receptor FLK-1, whi lst the non-mitogenic receptor FLT-1 was less frequently positive, suggesti ng that the tyrosine kinase FLK-1 is involved in malignant transformation o f neuroblastoma cells. However, neutralising antibodies to VEGF did not inh ibit growth of neuroblastoma cell lines, which argues against a role of VEG F as an autocrine growth factor, at least for cell lines in vitro. We concl ude that neuroblastoma cells produce VEGF, which may contribute to tumour v ascularisation, growth and invasion. (C) 1999 Elsevier Science Ltd. All rig hts reserved.